JACN
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mingrone, G.
Right arrow Articles by Gasbarrini, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mingrone, G.
Right arrow Articles by Gasbarrini, G.
Journal of the American College of Nutrition, Vol. 18, No. 1, 77-82 (1999)
Published by the American College of Nutrition

L-Carnitine Improves Glucose Disposal in Type 2 Diabetic Patients

Geltrude Mingrone, MD, PhD, FACN, Aldo V. Greco, MD, Esmeralda Capristo, MD, Giuseppe Benedetti, MD, Annalisa Giancaterini, MD, Andrea De Gaetano, PhDmath and Giovanni Gasbarrini, MD

Istituto di Medicina Interna, Catholic University, Rome, ITALY

Address reprint requests to: G. Mingrone, MD, PhD, FACN, Istituto di Medicina Interna, Università Cattolica del Sacro Cuore, L.go A. Gemelli, 8-00168 Roma, ITALY

Objective: Aim of the present study is to evaluate the effects of L-carnitine on insulin-mediated glucose uptake and oxidation in type II diabetic patients and compare the results with those in healthy controls.

Design: Fifteen type II diabetic patients and 20 healthy volunteers underwent a short-term (2 hours) euglycemic hyperinsulinemic clamp with simultaneous constant infusion of L-carnitine (0.28 µmole/kg bw/minute) or saline solution. Respiratory gas exchange was measured by an open-circuit ventilated hood system. Plasma glucose, insulin, non-esterified fatty acids (NEFA) and lactate levels were analyzed. Nitrogen urinary excretion was calculated to evaluate protein oxidation.

Results: Whole body glucose uptake was significantly (p<0.001) higher with L-carnitine than with saline solution in the two groups investigated (48.66±4.73 without carnitine and 52.75±5.19 µmoles/kgffm/minute with carnitine in healthy controls, and 35.90±5.00 vs. 38.90±5.16 µmoles/kgffm/minute in diabetic patients). Glucose oxidation significantly increased only in the diabetic group (17.61±3.33 vs. 16.45±2.95 µmoles/kgffm/minute, p<0.001). On the contrary, glucose storage increased in both groups (controls: 26.36±3.25 vs. 22.79±3.46 µmoles/kgffm/minute, p<0.001; diabetics: 21.28±3.18 vs. 19.66±3.04 µmoles/kgffm/minute, p<0.001). In type II diabetic patients, plasma lactate significantly decreased during L-carnitine infusion compared to saline, going from the basal period to the end-clamp period (0.028±0.0191 without carnitine and 0.0759±0.0329 with carnitine, p<0.0003).

Conclusions: L-carnitine constant infusion improves insulin sensitivity in insulin resistant diabetic patients; a significant effect on whole body insulin-mediated glucose uptake is also observed in normal subjects. In diabetics, glucose, taken up by the tissues, appears to be promptly utilized as fuel since glucose oxidation is increased during L-carnitine administration. The significantly reduced plasma levels of lactate suggest that this effect might be exerted through the activation of pyruvate dehydrogenase, whose activity is depressed in the insulin resistant status.

Key words: L-carnitine, euglycemic-hyperinsulinemic clamp, type 2 diabetes mellitus




This article has been cited by other articles:


Home page
 HypertensionHome page
R. Muniyappa
Oral Carnitine Therapy and Insulin Resistance
Hypertension, February 1, 2010; 55(2): e13 - e13.
[Full Text] [PDF]

Home page
 Biol. Reprod.Home page
M. C. Satterfield, H. Gao, X. Li, G. Wu, G. A. Johnson, T. E. Spencer, and F. W. Bazer
Select Nutrients and Their Associated Transporters Are Increased in the Ovine Uterus Following Early Progesterone Administration
Biol Reprod, January 1, 2010; 82(1): 224 - 231.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
P. Ruggenenti, D. Cattaneo, G. Loriga, F. Ledda, N. Motterlini, G. Gherardi, S. Orisio, and G. Remuzzi
Ameliorating Hypertension and Insulin Resistance in Subjects at Increased Cardiovascular Risk: Effects of Acetyl-L-Carnitine Therapy
Hypertension, September 1, 2009; 54(3): 567 - 574.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
R. C. Noland, T. R. Koves, S. E. Seiler, H. Lum, R. M. Lust, O. Ilkayeva, R. D. Stevens, F. G. Hegardt, and D. M. Muoio
Carnitine Insufficiency Caused by Aging and Overnutrition Compromises Mitochondrial Performance and Metabolic Control
J. Biol. Chem., August 21, 2009; 284(34): 22840 - 22852.
[Abstract] [Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
J. D Evans, T. F Jacobs, and E. W Evans
Role of Acetyl-L-Carnitine in the Treatment of Diabetic Peripheral Neuropathy
Ann. Pharmacother., November 1, 2008; 42(11): 1686 - 1691.
[Abstract] [Full Text] [PDF]

Home page
 J Gerontol A Biol Sci Med SciHome page
A. Bernard, C. Rigault, F. Mazue, F. L. Borgne, and J. Demarquoy
L-Carnitine Supplementation and Physical Exercise Restore Age-Associated Decline in Some Mitochondrial Functions in the Rat
J Gerontol A Biol Sci Med Sci, October 1, 2008; 63(10): 1027 - 1033.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
S. M. Fenkci, V. Fenkci, O. Oztekin, S. Rota, and N. Karagenc
Serum total L-carnitine levels in non-obese women with polycystic ovary syndrome
Hum. Reprod., July 1, 2008; 23(7): 1602 - 1606.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
G. Y. Yeh, D. M. Eisenberg, T. J. Kaptchuk, and R. S. Phillips
Systematic Review of Herbs and Dietary Supplements for Glycemic Control in Diabetes
Diabetes Care, April 1, 2003; 26(4): 1277 - 1294.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the American College of Nutrition.